A Technology-Leading CRO for 25+ Years

Founded in 1989, Nth Analytics is a CRO that employs a deliberately small team of SAS programmers and biostatisticians to handle mission-critical assignments with the precision expected by pharmaceutical and biotech organizations, and to work at the fore of technological advancements and requirements in the industry.


Recent projects

In collaboration with Dr. Mary Johnson, MJ Biostat:

  •  2018-19: Oncology studies; FDA submission deliverables using Pinnacle21 Enterprise, SAP; fully validated, standalone SDTM, ADaM, and TLG SAS programs suitable for regulatory submission; statistical analyses, tables, listings, and graphs.
  • 2018-19: Oncology study; unblinded statisticians for Data Monitoring Committee (DMC).  Statistical reports and follow-up analyses for DMC.
  • 2017: COPD study; fully validated, automated patient safety narratives for serious adverse events, preserving medical writers' comments in subsequent iterations.

Further:

  •  2017-18: Major Depressive Disorder study; statistical support for machine-learning analyses.  


Key Associates

Mike Todd, President

image19

Michael Todd has over 25 years of experience in SAS programming, and has been involved in technology-mandated projects such as Pinnacle21 Enterprise for CDISC-compliant FDA submissions, as well as having been an invited speaker at 3 CDISC Interchange conferences as a recognized CDISC expert.

Anne Russotto, Consultant

image20

Anne Russotto manages all project team activities at Nth Analytics, with extensive experience determining business requirements for all stages of clinical trials. She is also a CDISC SDTM expert with over 15 years of experience in management of CDISC implementation, as well as major contributions to the CDISC SDS team.

Wenjiong Zhou, Consultant










With over 20 years of experience in the pharmaceutical and CRO industry, Dr. Wenjiong Zhou has worked with Nth Analytics for the past 6 years as a senior biostatistician preparing  statistical analysis plans and responsible for the review and validation of project TLFs for the company.

Recent Publications and Presentations